Filing Flows › Comparisons › NUS vs MEDS
Nu Skin Enterprises vs DataMeds AI: NUS and MEDS compared
Nu Skin Enterprises is the larger company: $311M of revenue in its latest quarter (Q3 2026) against $1.8M for DataMeds AI (Q2 2026). Nu Skin Enterprises is growing faster (-15% against -77% a year earlier). Nu Skin Enterprises is more profitable, with an operating margin of 1.6% against -412.7%.
Where the money goes: NUS and MEDS
Nu Skin Enterprises (NUS) · Q3 2026
Nu Skin Enterprises, Q3 2026: revenue $311M (-15% year over year), operating margin 1.6%, net loss $742K, operating cash flow −$8.1M. The chart follows the revenue to costs, profit and cash.
DataMeds AI (MEDS) · Q2 2026
DataMeds AI, Q2 2026: revenue $1.8M (-77% year over year), operating margin -412.7%, net loss $18.4M, operating cash flow −$2.9M. The chart follows the revenue to costs, profit and cash.
| Nu Skin Enterprises (NUS) | DataMeds AI (MEDS) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $311M | $1.8M |
| Revenue growth, Y/Y | -15% | -77% |
| Operating margin | 1.6% | -412.7% |
| Net earnings | −$742K | −$18.4M |
| Net margin | -0.2% | — |
| Operating cash flow | −$8.1M | −$2.9M |
| Market value | $226M | — |
| Analysts’ mean target | $12.48 | — |
Where the revenue comes from
DataMeds AI
- Pharmacy Retail Sales: $1.6M (89%)
- Third Party Logistics Services: $123K (7%)
- Product: $67K (4%)
Questions
Which is bigger, Nu Skin Enterprises or DataMeds AI?
Nu Skin Enterprises is the larger company: $311M of revenue in its latest quarter (Q3 2026) against $1.8M for DataMeds AI (Q2 2026).
Is Nu Skin Enterprises or DataMeds AI growing faster?
Nu Skin Enterprises is growing faster (-15% against -77% a year earlier).
Which is more profitable, Nu Skin Enterprises or DataMeds AI?
Nu Skin Enterprises is more profitable, with an operating margin of 1.6% against -412.7%.
More: Nu Skin Enterprises earnings · how Nu Skin Enterprises makes money · DataMeds AI earnings · how DataMeds AI makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 6, 2026; 10-Q filed Aug 17, 2026). Fiscal quarters can end on different dates. Not investment advice.